Ecosystem

Announcing the graduation of our first BioDAO cohort, illustrating progress in the convergence of web3, biotechnology, and a new method for supporting research endeavors.

Albert, co-initiator of ValleyDAO, discovered DeSci through VitaDAO and received support from bio.xyz to launch the community-owned synbio innovation ecosystem. ValleyDAO focuses on advancing climate and food synthetic biology through three initial academic research projects.

SpineDAO, a decentralized science collective focused on transforming spine care, is set to redefine the sector with the successful completion of its $SPINE token generation event (TGE), raising $827,500 through the Bio Protocol launchpad.

MycoDAO, a decentralized science collective focused on fungi, has successfully completed its $MYCO token generation event (TGE), raising $468K via the Bio Protocol launchpad. $MYCO is now live on Solana, marking a major milestone in decentralized biotech.

Bio launched its first AI plugin for scientific research. MycoDAO and SpineDAO started their auctions. The Bio x AI Hackathon kicked off, and the DeSci Summit in Dubai brought the community together for a full day of talks.

Bio Monthly recaps Bio V1's launch on Solana and Base, featuring a permissionless launchpad, liquidity engine, and BioAgents, with 3.2M BIO tokens curated. It highlights new BioDAOs like MycoDAO and SpineDAO, Curetopia's $1.77M raise for rare diseases, and the Bio x AI Hackathon in Berlin with $125K+ in prizes.

Get ready to transform the future of biotechnology at the Bio x AI Hackathon. From March 31, 2025, participants worldwide will compete for a massive $125,000 prize pool, pushing the boundaries of AI-driven BioAgents, scientific tools, and decentralized biotech research.

Curetopia, the first Biotech DAO (BioDAO) on Solana, has raised $1.77M to develop treatments in the $1T+ rare disease space. The raise comes on the heels of a recent discovery by Curetopia which could lead to the first-ever treatment for a disease developed by a DeSci project, with proceeds flowing back to the DAO.

Bio V1, launching in the coming weeks, will consist of various components aimed at making early-stage biotech more permissionless and autonomous, including a launchpad, liquidity engine and BioAgents (AI-powered scientific agents integrated with BioDAOs).